This award will fund projects to advance understanding of how heat impacts anxiety, depression, and psychosis in the most impacted groups globally through biological, psychological, and/or social mechanisms. Teams must bring together mental health and climate expertise as well as additional expertise as relevant. Consistent with the Wellcome approach to mental health research, it is expected that research teams to include relevant lived experience of mental health problems, unless there is a strong justification for not doing so. Researchers can be based in institutions anywhere in the world (apart from mainland China and countries that are the target of international sanctions). Scope check deadline 18 December 2024.

Find out more and apply

About

The Victoria’s Secret Global Fund for Women’s Cancers Rising Innovator Research Grant, in Partnership with Pelotonia and the American Association for Cancer Research, is intended to fund innovative research projects in breast and gynecologic cancers and to invest in female scientists at the Associate Professor level domestically and globally to foster innovation in the understanding, prevention, interception, early detection, diagnosis, and treatment of these cancers with the goal of eliminating cancer health disparities and improving patient outcomes.

Proposed projects may be in basic, translational, clinical, or population sciences. Proposals focused on research into the causes of cancer health disparities and approaches to achieve equity in outcomes as well as applicants belonging to racial or ethnic groups shown to be underrepresented in the cancer-related sciences workforce are especially encouraged. 

ELIGIBILITY

Applicants must be female investigators with a doctoral degree. American Association for Cancer Research (AACR) membership or intention to apply. Applicants belonging to racial or ethnic groups shown to be underrepresented in the cancer-related sciences workforce are especially encouraged to apply. 

Amount

This grant provides USD$700,000 over three years. 

Apply to the The Victoria’s Secret Global Fund for Women’s Cancers Rising Innovator Research Grant

About

Notices of funding opportunities (NOFO) for HIV and TB work in Lesotho, the Dominican Republic, Malawi, Ukraine, Zambia, Central America and the Kingdom of Eswatini. 

• Sustaining HIV and TB epidemic control in Lesotho through health system strengthening and technical assistance under the President's Emergency Plan for AIDS Relief (PEPFAR). Closing date: 20 Feb 2025 
• Advancing country-led sustainable digital health transformation across PEPFAR-supported countries through informatics workforce capacity development to end HIV/AIDS and TB as a public health threat by 2030 under PEPFAR. Closing date: 21 Feb 2025 
• Improving HIV prevention and treatment in the Dominican Republic with a focus on priority populations under the President's Emergency Plan for AIDS Relief (PEPFAR). Closing date: 21 Feb 2025 
• Improving quality of care and health outcomes through innovative systems and technologies in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR). Closing date: 21 Feb 2025 
• Sustaining HIV services for key and priority populations through enhanced differentiated testing, innovative treatment and prevention approaches, and continuous support to Ukraine Ministry of Health, Public Health Center, and communities under PEPFAR. Closing date: 21 Feb 2025 
• Providing targeted technical assistance to the HIV/TB prevention-care-treatment continuum using cost efficient and scalable quality improvement approaches to address program gaps in support of sustainable HIV services in Zambia under PEPFAR. Closing date: 24 Feb 2025 

• Advancing national epidemiologic, surveillance, research and laboratory capacities and systems to support a sustainable and resilient response to HIV/TB and related public health threats in the Kingdom of Eswatini under PEPFAR. Closing date: 5 March 2025

• Building capacity along the continuum from prevention to care and treatment in the Central American region under the President's Emergency Plan for AIDS Relief (PEPFAR). Closing date: 24 February 2025

About

Notices of funding opportunities (NOFO) for global health and health care systems work in Kenya, Namibia, South Africa, Botswana, Zimbabwe, Malawi, Uganda, India, Botswana, Sierra Leone, Tanzania and Caribbean countries. 

• Innovative Approaches for TB Prevention and Case Finding to END TB. Closing date: 3 March 2025 
• Supporting sustainable, accessible, integrated and quality laboratory systems for HIV/TB and related health threats in the Republic of Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR). Closing date: 20 February 2025 
• Strengthening the Government of Namibia’s health information systems (HIS) to improve public health programs under the President's Emergency Plan for AIDS Relief (PEPFAR). Closing date: 20 February 2025 
• Strengthening economic analysis and capacity in support of program management for HIV, TB, and related health threats in South Africa (SA) under the President's Emergency Plan for AIDS Relief (PEPFAR). Closing date: 20 February 2025 
• Combination prevention solutions to reach epidemic control among high risk, priority populations in high burden areas in South Africa (SA) under the PEPFAR. Closing date: 20 February 2025 
• Strengthening the Botswana Ministry of Health (MOH) laboratory and health systems through technical assistance (TA) to effectively manage and sustain a quality HIV/TB program in Botswana under the PEPFAR. Closing date: 19 February 2025 
• Strengthening comprehensive HIV and TB services and health systems in high-burden areas of Namibia under the PEPFAR. Closing date: 19 February 2025 
• Provide technical assistance to the Botswana Ministry of Health to implement HIV/TB policies and services for children and adolescents living with HIV including mental health and psychosocial support and pregnant and breastfeeding women under the PEPFAR. Closing date: 19 February 2025 
• Provide technical assistance (TA) to support the Botswana Ministry of Health (MOH) implement policies and programs across the HIV clinical and prevention cascade under the PEPFAR. Closing date: 19 February 2025 
• Implementation of integrated, resilient, and sustainable health systems for HIV/TB epidemic control in the Republic of Kenya under the PEPFAR. Closing date: 19 February 2025 
• Supporting the implementation of comprehensive HIV prevention and treatment programs to achieve and sustain epidemic control in Zimbabwe under the PEPFAR. Closing date: 18 February 2025 
• Support for laboratory diagnosis and monitoring to scale up and improve HIV/AIDS care and treatment services for Caribbean countries supported under the PEPFAR. Closing date: 18 February 2025 
• Strengthening comprehensive HIV prevention interventions in Malawi under the PEPFAR. Closing date: 18 February 2025 
• Strengthening civil society organizations' capacity and coordination to accelerate HIV epidemic control in Uganda by implementing comprehensive HIV/AIDS prevention and treatment for key and priority populations under the PEPFAR. Closing date: 18 February 2025 
• Strengthening and modernizing sustainable public health systems and workforce in Uganda for data science, informatics, surveys, and surveillance for timely, accurate, and integrated data for action under the PEPFAR. Closing date: 18 February 2025 
• Ending HIV as a public health threat by sustaining and accelerating a comprehensive HIV and TB response in India under the PEPFAR. Closing date: 24 February 2025
• Strengthening Botswana's national health data systems for a sustainable and government-led HIV/TB and related public health threat response through enhanced surveillance, digital health, and data analytics under the PEPFAR. Closing date: 24 February 2025
• Strengthening the national HIV care and treatment program in Sierra Leone (SL) to accelerate the response to end the HIV/AIDS pandemic as a public health threat by 2030, under the PEPFAR. Closing date 24 February 2025
• Capacity building and technical assistance for sustainable community-led monitoring (CLM) of HIV services in Sierra Leone (SL) under the PEPFAR. Closing date: 24 February 2025
• Implement and sustain a comprehensive response to HIV and technical assistance to strengthen the capacity of regional authorities in the United Republic of Tanzania under PEPFAR. Closing date: 25 February 2025
• Strengthening India’s integrated HIV/STI tiered laboratory network through continuous quality improvement, surveillance, and laboratory data management under the PEPFAR. Closing date: 25 February 2025

About

This call offers opportunities for NIHR GHR Academy Members to spend time in other NIHR Global Health Research Programmes or different parts of the NIHR, including overseas partner institutions and industry partners with existing NIHR links. On their GHR SPARC placement, GHR Academy members will get the opportunity to: network, learn a specific skill, collaborate with other researchers/specialists, increase their understanding of NIHR funding and enhance their career development. 

ELIGIBILITY

This opportunity is open to NIHR GHR Academy Members. A NIHR GHR Academy Member is someone who is receiving funding from, or being supported by, an NIHR Global Health Research programme to develop their academic career. Your NIHR GHR programme must have a contract end date after 31 December 2025 and you must currently be undertaking a Pre-doctoral fellowship/Masters, PhD or Post-doctoral fellowship or being supported to apply for a formal training/career development award 

Amount

Up to £10,000 

Deadline

13 February 2024   

Apply for NIHR: Global Health Research Short Placement Award for Research Collaboration 

ABOUT

This funding call will generate a body of evidence on the health effects of climate change mitigation interventions in low- and middle-income countries (LMICs). This award will fund transdisciplinary research teams, led by an applicant at an LMIC-based institution. Research funded will investigate health effects alongside the social and economic impacts of planned or implemented greenhouse gas mitigation strategies. Research will reflect local priorities and produce evidence to drive positive climate and health outcomes. Webinar 9 December 2024. Preliminary application deadline: 18 February 2025. 

AMOUNT

£500,000-£2 million per project for 2 - 4 years  

Frequency: One-off  

ELIGIBILITY

Lead applicant career stage: Established researcher  

Co-applicants: Accepted 

Administering organisation location:  Low- or middle-income countries (apart from mainland China)  

Apply for the Wellcome Climate and Health Award

About

This programme gives ODA-eligible early-career to senior researchers the opportunity to work with peers around the world to inform policymaking through quality evidence and research. Only open to proposals related to evidence-informed policy-making in Brazil, Egypt, Indonesia, Jordan, Kenya, Malaysia, Philippines, South Africa, Turkey, Thailand, Vietnam and/or Least Developed Countries. This programme is part of the £337m International Science Partnerships Fund, which is designed to enable potential and foster prosperity.   

This programme will support grants in the following areas: 

• Research related to how evidence use theory and research has been implemented in practice. 
• Research or research-based activities related to knowledge systems strengthening and/or organisational change to support evidence use in practice. 
• Knowledge systems strengthening and/or organisational change to support evidence use in practice. 

The Academy is looking to support awards that work in the following fields: 

• Environment, Sustainability & Nature 
• Transformative Technologies 
• Health & Wellbeing 
• Cities & Urbanisation 
• Global Order, Geopolitics and International Affairs 

Eligibility

The PI must be of postdoctoral or above status (or have equivalent research experience). The PI must hold an established role in an eligible university or research institute in the UK, Brazil, Egypt, Indonesia, Jordan, Kenya, Malaysia, Philippines, South Africa, Turkey, Thailand, Vietnam and/or Least Developed Countries. Applications for this funding must be ODA-eligible.  

Amount

Awards are for a period of 12 months, with a maximum award value of £150,000.   

Apply to the British Academy: Evidence informed policymaking grants

About

A grant will be awarded to provide funds to develop exciting investigator-initiated concepts focused on global health research, which will hopefully lead to successful longer term project funding from the NIH or equivalent funding sources. Examples of global health research include, but are not limited to telemedicine (e.g., remote planning of radiotherapy, or AI-supported automatic cancer prediction from screening data of cancers common in LMIC), development of low-cost technologies for diagnostics and treatment (e.g., auto-contouring of clinical targets applied to clinical trials in LMIC). Inclusion of existing global health research resources (e.g., AAPM GRSIC open source tools, or international clinical trial data). 

Applications aligning with the American Association of Physicists in Medicine’s (AAPM) strategic priorities are especially encouraged, particularly in the following areas: 

• Strategic Priority 1: Global health research in emerging medical physics fields such as radiopharmaceutical therapies and expanding beyond the usual radiology and radiation oncology. 
• Strategic Priority 2: Global health research in computational physics integrating AI/ML/DT technologies. 

Eligibility

Must be a member of American Association of Physicists in Medicine (AAPM) at the time of application (any membership category). Pending membership status not eligible. 10 years or less since receipt of a terminal research degree or medical physics residency, whichever is later. (Excludes those who have reached Associate Professor level; includes Postdoctoral Fellows with mentors and Research Scientists with mentors.)  

Amount

USD$25,000 

Apply to the Global Health Research Seed Funding Grant

About

Funding to develop and test novel therapeutics, medical devices, diagnostics You can apply for academically-led translational projects that aim to either:

• improve prevention, diagnosis, prognosis or treatment of significant health needs
• develop research tools that increase the efficiency of developing interventions.

All diseases and interventions are eligible for support. You can also address global health issues. Your project can start and finish at any stage on the developmental pathway from early development, through pre-clinical refinement and testing to early-phase clinical studies and trials (up to phase 2a). You can submit follow-on proposals where you can justify the need for continued support. This is an ongoing funding opportunity. Application rounds close every March, July and November.

Amount

No limits

Apply to the MRC: Developmental Pathway Funding scheme

About

The 2025 calls will support a range of research and innovation actions (RIA) aimed at developing novel vaccines and therapeutics for tuberculosis, malaria and neglected tropical diseases. Additionally, coordination and support actions (CSA) strengthening the enabling environment for conducting clinical research in Africa will be funded at the individual level through fellowships in public health with emphasis on the areas of biostatistics, epidemiology, and modelling, as well as at the institutional level through regional networks of excellence for preparedness and response to outbreaks. Four calls for proposals will be launched: 
 
1) HORIZON-JU-GH-EDCTP3-2025-01-two-stage covering 3 topics for Research and Innovation Actions (RIA): 

• HORIZON-JU-GH-EDCTP3-2025-01-TB-01-two-stage: Global collaboration action for the development of vaccines for reducing the disease burden of Tuberculosis in sub-Saharan Africa; 
• HORIZON-JU-GH-EDCTP3-2025-01-MALARIA-02-two-stage: Global collaboration action for research on existing Malaria therapeutics and clinical development of new antimalarial candidates; 
• HORIZON-JU-GH-EDCTP3-2025-01-NTD-03-two-stage: Accelerating the development of prophylactic vaccines against Neglected Tropical Diseases (NTDs) in sub-Saharan Africa. 

 2) HORIZON-JU-GH-EDCTP3-2025-02-two-stage covering 1 topic for Coordination and Support Actions (CSA): 

• HORIZON-JU-GH-EDCTP3-2025-02-FELLOWSHIP-01-two-stage: Global Health EDCTP3 and contributing partners funded Strategic Training Hubs for Fellowships in Public Health covering Biostatistics, Epidemiology and Modelling. 

 3) HORIZON-JU-GH-EDCTP3-2025-03-two-stage covering 1 topic for Coordination and Support Actions (CSA): 

• HORIZON-JU-GH-EDCTP3-2025-03-NETWORKS-01-two-stage: Global collaborative action for strengthening the Regional Networks of Excellence and Epidemic Preparedness Consortia. 

 4) HORIZON-JU-GH-EDCTP3-2025-04-two-stage covering 2 topics Research and Innovation Actions (RIA): 

• HORIZON-JU-GH-EDCTP3-2025-04-CH-01-two-stage: Global collaborative action tackling diarrhoeal diseases in the context of climate and health; 
• HORIZON-JU-GH-EDCTP3-2025-04-ACCESS-02-two-stage: Transformative Innovations in global health. 

Amount

The total budget is €214 million. Expected JU contribution per project are worth between €1.34m and €15.3m. 

Deadline

The calls for proposals will open in late January 2025. Interested consortia are invited to submit a short proposal by March 2025 (first stage). Successful consortia will then be invited to submit a full proposal by September 2025 (second stage).   

Apply to the EDCTP: HORIZON-JU-GH-EDCTP3-2025 

About

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage exploratory/developmental research applications that propose to study the development, validation, feasibility, and effectiveness of innovative mobile health (mHealth) interventions or tools specifically suited for low- and middle-income countries (LMICs) that utilize new or emerging technology, platforms, systems, and/or analytics. The overall goal of the program is to catalyze innovation through multidisciplinary research that addresses global health problems, develop an evidence base for the use of mHealth technology to improve clinical and public health outcomes, and strengthen mHealth research capacity in LMICs. 

This NOFO provides support for up to two years (R21 phase) for technology development and feasibility studies, followed by a possible transition to expanded research support (R33 phase) for validation, larger-scale feasibility, and effectiveness studies. Transition to the R33 depends on the completion of applicant-defined milestones, as well as program priorities and the availability of funds. All applicants must address both the R21 and R33 phases. 

Amount

Maximum award USD $800,000 

Apply to the NIH: Mobile Health: Technology and Outcomes in Low and Middle Income Countries

ABOUT

This annual grant offers early career researchers and global health professionals based anywhere in the world the opportunity to apply for funding in a topic related to tropical medicine and global health. In 2024 the RSTMH funded more than 220 Early Career Grants, their highest number yet.*** This opportunity will be available soon. The next call is expected to open in January 2025. This information is subject to change. ***

AMOUNT

Up to £5,000 over 1 year (including VAT).

ELIGIBILITY

Early career researchers and global health professionals based anywhere in the world, who have not had research funding in their own name before.

Apply to the Royal Society of Tropical Medicine and Hygiene: Early Career Grants Programme

About

This call supports implementation research addressing strategies for strengthening of health systems to improve equity in high quality care and health outcomes and reduce the prevalence and impact of chronic non-communicable diseases (NCDs) in low- and middle-income countries and/or in underserved populations experiencing health disparities such as Indigenous populations, in high-income countries.

Applicants to the 2025 funding call are invited to propose appropriately designed and targeted implementation research to support health system transformation and/or strengthening using evidence-based interventions that can be adapted to, and implemented in, LMICs and populations experiencing health disparities to encourage equitable health outcomes and decrease the burden of NCDs.

Process

GACD uses a a two-step application process. Applicants will need to submit a brief first stage proposal, which will be peer reviewed. All applicants will be provided with feedback from the first stage review process and successful applicants will be invited to submit a second stage proposal.

Webinar for prospective applicants: GACD will hold a webinar for prospective applicants in March 2025.

Key dates

Application Portal opens: 4 February 2025
Participating funding agencies confirmed: 28 March 2025
First stage proposal deadline: 16 June 2025 (18:00 CET)
First Stage proposal outcomes: 10 September 2025
Second stage proposal deadline: 22 October 2025 (18:00 CET)
Awards: January-April 2026

More info on the GACD Strengthening Health Systems opportunity